Results 261 to 270 of about 11,441,017 (408)
Rewiring cell identity and metabolism to drive cardiomyocyte proliferation. [PDF]
Zheng L, Chen Y, Xiong JW.
europepmc +1 more source
The postnatal growth of the kidney of the albino rat, with observations on an adult human kidney [PDF]
John A. Kittelson
openalex +1 more source
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source
Temporal Variation in Early-Life Conditions Impacts on Later-Life Levels of Infection in Sex Specific Ways. [PDF]
Ravenswater HM+10 more
europepmc +1 more source
Adult human ovaries with follicles containing several oöcytes [PDF]
Lloyd Arnold
openalex +1 more source
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim+11 more
wiley +1 more source
Cost Assessment of Pediatric Haploidentical Hematopoietic Stem Cell Transplantation. [PDF]
Achour L+5 more
europepmc +1 more source
ADULT SCURVY AND THE METABOLISM OF VITAMIN C
Elaine P. Ralli, Sol Sherry
openalex +1 more source
Observations on the blood capillaries in the cerebellar cortex of normal young adult domestic cats [PDF]
Frank S. Aby
openalex +1 more source
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez+5 more
wiley +1 more source